Botanical species · safety record

Carthamus lanatus

The EFSA Compendium of Botanicals holds 2 constituent measurements and 1 genotoxicity assay for Carthamus lanatus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Carthamus lanatus L.

2Constituent measurements
1Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Alkaloids1
  • Saponins1

Plant parts

  • Unspecified2

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AlkaloidsUnspecifiedSolvent extraction0.176 Milligram/100 gramPhytochemical screeningNo resolvable identifier
SaponinsUnspecifiedSolvent extraction2.516 Milligram/100 gramPhytochemical screeningNo resolvable identifier

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Negativechromosome aberration assayHouse mouse (as animal)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hussain, Iqbal., Ullah, Riaz., Ullah, Rooh., Khurram, Muhammad., Ullah, Naseem., Baseer, Abdul., Khan, Farhat Ali., ur Rehman Khattak, Muneeb., Zahoor, Mohammad., Khan, Jehangir., et al. Phytochemical analysis of selected medicinal plants. African Journal of Biotechnology, 2011, p. 7487-7492.
  2. Topashka-Ancheva, M., Taskova, R., Handjieva, N., Mikhova, B., Duddeck, H. Clastogenic effect of Carthamus lanatus L. (Asteraceae). ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 2003, vol. 58, no. 11-12, p. 833-836.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue